Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.70−0.06 (-3.41%)
Close on Nov 16, 2026Market cap $1.31MP/E –Yield –
Jupiter Neurosciences ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Jupiter Neurosciences
Jupiter Neurosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?